Daisy Cai is a General Partner at B Capital focused on investing in technology and AI across the US and Asia. At B Capital, she has invested in and serves on the board of companies such as Writer.ai, EvenUp, Profound Bio (acquired by Genmab), Prothentic, Insilico and Spectrumedic, etc.

Daisy has nearly two decades of investment experience. She was formerly a Partner at Softbank Vision Fund. She also held investing roles at Goldman Sachs and TA Associates. She started her career as a chip architect designer at Advanced Micro Devices (AMD) in Silicon Valley.

Daisy earned an MS degree in Electrical Engineering from the University of Southern California and an MBA from Columbia Business School. She is based in San Francisco.